Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

To get patent/product expiration details and freedom-to-operate opportunities

— API development, India

To find drug patent expiry dates in Europe

— Analyst, Switzerland

To gain knowledge on formulations of different drugs

— Product development officer, Pharmaceutical company, Bangladesh

To follow up on status of patents in Colombia and other Latin American countries

— Business development, Colombia

For patent related information to plan launch of generics worldwide

— Director, international business, India

Generated: May 26, 2017

DrugPatentWatch Database Preview

Details for Patent: 9,192,608

« Back to Dashboard

Which drugs does patent 9,192,608 protect, and when does it expire?


Patent 9,192,608 protects MORPHINE SULFATE and is included in one NDA.

This patent has six patent family members in six countries.

Summary for Patent: 9,192,608

Title:Morphine formulations
Abstract: Provided herein, generally, are pharmaceutical formulations, e.g., injectable pharmaceutical formulations with improved stability, comprising morphine sulfate or a hydrate thereof, and methods of producing and using the same. Also provided herein are kits comprising the formulations, e.g., injectable morphine formulations.
Inventor(s): Cuine; Alain (St. Fargeau-Ponthierry, FR), Hoarau; Didier (Claix, FR), Romain; Pauline (Saint Egreve, FR)
Assignee: BECTON DICKINSON FRANCE S.A.S. (Le Pont de Claix, FR)
Application Number:14/715,277
Patent Claim Types:
see list of patent claims		Use; Formulation;

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Fresenius Kabi Usa
MORPHINE SULFATE
morphine sulfate
SOLUTION;INTRAMUSCULAR, INTRAVENOUS204223-001Oct 30, 2013RXYesYes9,192,608► Subscribe TREATMENT OF PAIN
Fresenius Kabi Usa
MORPHINE SULFATE
morphine sulfate
SOLUTION;INTRAMUSCULAR, INTRAVENOUS204223-001Oct 30, 2013RXYesYes9,192,608► Subscribe MANAGEMENT OF CHRONIC PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA
Fresenius Kabi Usa
MORPHINE SULFATE
morphine sulfate
SOLUTION;INTRAMUSCULAR, INTRAVENOUS204223-002Oct 30, 2013RXYesYes9,192,608► Subscribe MANAGEMENT OF CHRONIC PAIN IN PATIENTS REQUIRING OPIOID ANALGESIA
Fresenius Kabi Usa
MORPHINE SULFATE
morphine sulfate
SOLUTION;INTRAMUSCULAR, INTRAVENOUS204223-002Oct 30, 2013RXYesYes9,192,608► Subscribe TREATMENT OF PAIN
Fresenius Kabi Usa
MORPHINE SULFATE
morphine sulfate
SOLUTION;INTRAMUSCULAR, INTRAVENOUS204223-003Oct 30, 2013RXYesYes9,192,608► Subscribe TREATMENT OF PAIN
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 9,192,608

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,072,781Morphine formulations► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 9,192,608

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China104042565► Subscribe
European Patent Office2968132► Subscribe
Japan2016512210► Subscribe
Australia2014230834► Subscribe
Canada2902343► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

To check antibiotic drug patent information

— Pharmacist, Denmark

To identify business opportunities and check patent rights

— Managing director pharmaceutical company, Morocco

To checking the status of drug patents

— Market research, Vietnam

To perform literature and patent searches

— Life science entrepreneur, USA

To know what drugs are coming off patent over the next 5 years

— CRO business development manager, USA

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Related Products from thinkBiotech
Links

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot